OBJECTIVE: This study evaluated the effect of a Computerized Physician Order Entry system with basic Clinical Decision Support (CPOE/CDSS) on the incidence of medication errors (MEs) and preventable adverse drug events (pADEs). DESIGN: Interrupted time-series design. MEASUREMENTS: The primary outcome measurements comprised the percentage of medication orders with one or more MEs and the percentage of patients with one or more pADEs. RESULTS: Pre-implementation, the mean percentage of medication orders containing at least one ME was 55%, whereas this became 17% post-implementation. The introduction of CPOE/CDSS has led to a significant immediate absolute reduction of 40.3% (95% CI: -45.13%; -35.48%) in medication orders with one or more errors. Pre-implementation, the mean percentage of admitted patients experiencing at least one pADE was 15.5%, as opposed to 7.3% post-implementation. However, this decrease could not be attributed to the introduction of CPOE/CDSS: taking into consideration the interrupted time-series design, the immediate change was not significant (-0.42%, 95% CI: -15.52%; 14.68%) because of the observed underlying negative trend during the pre-CPOE period of -4.04% [95% CI: -7.70%; -0.38%] per month. CONCLUSIONS: This study has shown that CPOE/CDSS reduces the incidence of medication errors. However, a direct effect on actual patient harm (pADEs) was not demonstrated.
OBJECTIVE: This study evaluated the effect of a Computerized Physician Order Entry system with basic Clinical Decision Support (CPOE/CDSS) on the incidence of medication errors (MEs) and preventable adverse drug events (pADEs). DESIGN: Interrupted time-series design. MEASUREMENTS: The primary outcome measurements comprised the percentage of medication orders with one or more MEs and the percentage of patients with one or more pADEs. RESULTS: Pre-implementation, the mean percentage of medication orders containing at least one ME was 55%, whereas this became 17% post-implementation. The introduction of CPOE/CDSS has led to a significant immediate absolute reduction of 40.3% (95% CI: -45.13%; -35.48%) in medication orders with one or more errors. Pre-implementation, the mean percentage of admitted patients experiencing at least one pADE was 15.5%, as opposed to 7.3% post-implementation. However, this decrease could not be attributed to the introduction of CPOE/CDSS: taking into consideration the interrupted time-series design, the immediate change was not significant (-0.42%, 95% CI: -15.52%; 14.68%) because of the observed underlying negative trend during the pre-CPOE period of -4.04% [95% CI: -7.70%; -0.38%] per month. CONCLUSIONS: This study has shown that CPOE/CDSS reduces the incidence of medication errors. However, a direct effect on actual patient harm (pADEs) was not demonstrated.
Authors: Jasperien E van Doormaal; Peter G M Mol; Rianne J Zaal; Patricia M L A van den Bemt; Jos G W Kosterink; Karin M Vermeulen; Flora M Haaijer-Ruskamp Journal: J Eval Clin Pract Date: 2010-06-10 Impact factor: 2.431
Authors: Yong Y Han; Joseph A Carcillo; Shekhar T Venkataraman; Robert S B Clark; R Scott Watson; Trung C Nguyen; Hülya Bayir; Richard A Orr Journal: Pediatrics Date: 2005-12 Impact factor: 7.124
Authors: R S Evans; S L Pestotnik; D C Classen; T P Clemmer; L K Weaver; J F Orme; J F Lloyd; J P Burke Journal: N Engl J Med Date: 1998-01-22 Impact factor: 91.245
Authors: Ross Koppel; Joshua P Metlay; Abigail Cohen; Brian Abaluck; A Russell Localio; Stephen E Kimmel; Brian L Strom Journal: JAMA Date: 2005-03-09 Impact factor: 56.272
Authors: D W Bates; L L Leape; D J Cullen; N Laird; L A Petersen; J M Teich; E Burdick; M Hickey; S Kleefield; B Shea; M Vander Vliet; D L Seger Journal: JAMA Date: 1998-10-21 Impact factor: 56.272
Authors: Brian L Strom; Rita Schinnar; Joshua Jones; Warren B Bilker; Mark G Weiner; Sean Hennessy; Charles E Leonard; Peter F Cronholm; Eric Pifer Journal: J Am Med Inform Assoc Date: 2011-11-09 Impact factor: 4.497
Authors: Aileen B Dequito; Peter G M Mol; Jasperien E van Doormaal; Rianne J Zaal; Patricia M L A van den Bemt; Flora M Haaijer-Ruskamp; Jos G W Kosterink Journal: Drug Saf Date: 2011-11-01 Impact factor: 5.606
Authors: Rianne J Zaal; Mark M P M Jansen; Marjolijn Duisenberg-van Essenberg; Cees C Tijssen; Jan A Roukema; Patricia M L A van den Bemt Journal: Int J Clin Pharm Date: 2013-05-29
Authors: Carolien M J van der Linden; Paul A F Jansen; René J E Grouls; Rob J van Marum; Marianne A J W Verberne; Lieke M A Aussems; Toine C G Egberts; Erik H M Korsten Journal: Ther Adv Drug Saf Date: 2013-04